The global controlled release drug delivery market is poised to grow at a CAGR of 9.26% from 2023 to 2032. Main drivers of expansion are:
1 in 10 adults are actively prescribed antidepressants in the US
There were 10 Billion extended release antidepressants sold globally in 2023. Spektus delivers improved formulations of established XR antidepressant drugs.